Article
Review of CFTR modulators 2020.
Pediatric pulmonology - 1 Dec 2021
Goetz Danielle M, Savant Adrienne P
Abstract excerpt
Cystic fibrosis transmembrane conductance regulator (CFTR) modulators are small molecules that directly impact the CFTR protein, improving the function of the CFTR chloride and bicarbonate channel. Beginning in 2012 with the Food and Drug Administration approval of the first CFTR modulator, ivacaftor, this class of medications has had largely positive effects on many outcomes in people with cystic fibrosis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
